Tajikistan Tech Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tajikistan Tech Daily.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 10, 2025

November 10, 2025

uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire

November 10, 2025

Outdoor Holding Company Reports Positive Net Income from Continuing Operations for Second Quarter Fiscal 2026

GlobeNewswire

November 10, 2025

Immunocore to present at upcoming investor conferences

GlobeNewswire

November 10, 2025

Rhythm Pharmaceuticals Announces Presentation of Four Datasets at ObesityWeek® 2025

GlobeNewswire

November 10, 2025

Editas Medicine Announces Third Quarter 2025 Results and Business Updates

GlobeNewswire

November 10, 2025

Atana Unveils Organizational Insights to Close Learning Gaps and Reduce Risk Through Strategic Intelligence

GlobeNewswire

November 10, 2025

Apogee Therapeutics Announces Positive Interim Phase 1 Results from Healthy Volunteer Trial of APG333, its Novel Half-Life Extended TSLP Antibody

GlobeNewswire

November 10, 2025

Septerna Highlights Company Progress and Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 10, 2025

Orbus Therapeutics Announces Oral Presentation of Updated Results With Blinded Independent Central Review from the Phase 3 STELLAR Clinical Trial at the Society for Neuro-Oncology Annual Meeting

GlobeNewswire

November 10, 2025

Kamada Reports Strong Third Quarter and Nine Month 2025 Financial Results with over 30% Year-over-Year Profitability Growth

GlobeNewswire

November 10, 2025

HCW Biologics Shares the Latest Data for its Second-Generation Immune Checkpoint Inhibitor Presented at the 40th Annual Meeting of the Society for Immunotherapy of Cancer

GlobeNewswire

November 10, 2025

Tenaya Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

November 10, 2025

Day One Announces New OJEMDA™ (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting

GlobeNewswire

November 10, 2025

AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression

GlobeNewswire

November 10, 2025

CervoMed Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

GlobeNewswire

November 10, 2025

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update

GlobeNewswire

November 10, 2025

Galecto Announces Acquisition of Damora Therapeutics

GlobeNewswire

November 10, 2025

Bitdeer Reports Unaudited Financial Results for the Third Quarter of 2025

GlobeNewswire

November 10, 2025

Nurix Therapeutics Appoints Accomplished Biopharmaceutical Leader Roger Dansey, M.D., to Its Board of Directors

GlobeNewswire

November 10, 2025

Cogent Biosciences Reports Positive Results from Bezuclastinib PEAK Phase 3 Trial in Gastrointestinal Stromal Tumors (GIST)

GlobeNewswire